Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer

被引:24
|
作者
Kruk, PA
Godwin, AK
Hamilton, TC
Auersperg, N
机构
[1] Univ S Florida, Dept Pathol, Tampa, FL 33612 USA
[2] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
[3] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V6T 1Z3, Canada
关键词
D O I
10.1006/gyno.1999.5348
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Increased telomeric instability in normal ovarian surface epithelium may contribute to ovarian carcinogenesis in women from families with a high frequency of breast/ovarian cancer. To test this hypothesis, we compared proliferative potential, mean telomeric length, and telomerase activity in SV-40 large T-antigen transfected cell lines derived from normal ovarian surface epithelium of women with and without a familial history of breast/ovarian cancer. Methods. Telomeric instability was examined in SV-40 large T-antigen transfected cell lines of normal ovarian surface epithelium from patients with (FHIOSE, N = 5) and without (NFHIOSE, N = 11) a history of familial breast/ovarian cancer, The duration and total attainable number of population doublings, mean telomeric length, rate of telomeric loss, and telomerase activity were determined by cell counts, Southern blot analysis, and PCR ELISA. Results. FHIOSE cells attained fewer population doublings than NFHIOSE cells and doubled at approximately half the rate of NFHIOSE cells, indicating a reduced proliferative capacity in FHIOSE cells. While telomerase activity was not detected in FHIOSE or NFHIOSE cell lines, mean telomeric lengths in FHIOSE were generally 1 kb shorter than in NFHIOSE cells and the rate of telomeric loss as a function of population doublings was up to threefold greater in FHIOSE cells, Conclusions. Increased telomeric instability and reduced growth potential suggest greater proximity to replicative senescence in ovarian surface epithelium from women with a familial history of breast/ ovarian cancer. Consequently, an accumulation of genetic aberrations due to accelerated cellular aging may contribute to the enhanced susceptibility for malignant transformation and earlier onset in heritable ovarian cancer. (C) 1999 Academic Press.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 50 条
  • [41] Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer
    Rosen, Daniel G.
    Yang, Gong
    Bast, Robert C., Jr.
    Liu, Jinsong
    REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY, 2006, 407 : 660 - +
  • [42] Steroid Regulated Expression of the SLIT/ROBO Pathway in Human Ovarian Surface Epithelial Cells and Ovarian Cancer
    Dickinson, Rachel E.
    Fegan, K. Scott
    Hillier, Stephen G.
    Duncan, W. Colin
    REPRODUCTIVE SCIENCES, 2009, 16 (03) : 89A - 89A
  • [43] Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
    Andersen, M. Robyn
    Thorpe, Jason
    Buist, Diana S. M.
    Beatty, J. David
    Watabayashi, Kate
    Hanson, Nancy
    Resta, Robert
    Chubak, Jessica
    Urban, Nicole
    BEHAVIORAL MEDICINE, 2016, 42 (01) : 18 - 28
  • [44] Oral contraceptive use and risk of ovarian cancer in women with a family history of cancer.
    Olsson, JK
    Ziogas, A
    Brewster, W
    Anton-Culver, H
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 81A - 81A
  • [45] Breast screening outcomes in women with and without a family history of breast and/or ovarian cancer
    Halapy, EE
    Chiarelli, AM
    Klar, N
    Knight, J
    JOURNAL OF MEDICAL SCREENING, 2004, 11 (01) : 32 - 38
  • [46] Living with chronic risk: healthy women with a family history of breast/ovarian cancer
    Kenen, R
    Ardern-Jones, A
    Eeles, R
    HEALTH RISK & SOCIETY, 2003, 5 (03) : 315 - 331
  • [47] Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer
    Eltabbakh, GH
    Piver, MS
    Hempling, RE
    Recio, FO
    Aiduk, C
    GYNECOLOGIC ONCOLOGY, 1997, 66 (01) : 103 - 107
  • [48] Family History and Women With Ovarian Cancer: Is it Asked and Does it Matter? An Observational Study
    Lanceley, Anne
    Eagle, Zara
    Ogden, Gemma
    Gessler, Sue
    Razvi, Khalil
    Ledermann, Jonathan A.
    Side, Lucy
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (02) : 254 - 259
  • [49] Diet and predictors of dietary intakes in women with family history of breast and/or ovarian cancer
    McEigot, Archana J.
    Mouttapa, Michele
    Ziogas, Argyrios
    Anton-Culver, Hoda
    CANCER EPIDEMIOLOGY, 2009, 33 (06) : 419 - 423
  • [50] COST-UTILITY ANALYSIS OF THE GERMLINE BRCA TESTING IN WOMEN WITH EPITHELIAL OVARIAN CANCER WITHOUT FAMILY HISTORY IN SPAIN
    Gonzalez-Dominguez, A.
    Moya, C.
    Simon, S.
    Jimenez-Torres, M.
    Bayo-Lozano, E.
    Sanchez-Heras, A.
    Gonzalez-Martin, A.
    VALUE IN HEALTH, 2018, 21 : S47 - S47